Mayo Clinic launches two companies to help drive remote diagnostics initiative

Mayo Clinic announced Wednesday that it launched two new companies, Anumana and Lucem Health, to support its newly created remote diagnostics and management platform (RDMP). According to the medical centre, the platform is designed to provide the "next generation of clinical decision support tools, diagnostic insights and care recommendations" by connecting data with new artificial intelligence (AI) algorithms.

John Halamka, president of Mayo Clinic Platform, remarked that "with RDMP, clinicians will have access to best-in-class algorithms and care protocols, and will be able to serve more patients effectively in remote-care settings. The platform will also enable patients to…make better decisions based on insights delivered directly to them."

Anumana to develop AI-enabled algorithms

Anumana, which Mayo Clinic formed in collaboration with AI-driven health technology company nference, will create and commercialise digital sensor diagnostics by applying nference AI to Mayo Clinic's vast repository of medical data. Anumana's initial focus will be on designing neural network algorithms based on "billions" of relevant pieces of heart health data in Mayo Clinic's clinical data analytics platform, including raw electrocardiogram (ECG) signals, to enable early detection of heart disease.

Murali Aravamudan, CEO of nference and Anumana, said "our augmented intelligence technology…will enable a comprehensive translation of the language of the heart." Anumana's chief business officer David McMullin indicated that the goal is to gain FDA approval this year.

Lucem platform collects data from any device

Meanwhile, Lucem Health, which was launched in collaboration with Commure, has developed a platform that "collects, orchestrates and curates data from virtually any device." The platform will be used for connecting remote patient telemetry devices with AI-enabled algorithms, including those developed by Anumana and Mayo Clinic, and will also integrate diagnostic insights generated by these algorithms into clinical workflows.

According to Lucem CEO Sean Cassidy, "the idea is to connect these devices with these powerful algorithms and deliver the insights…the signals that we separate from the noises, to the right place at the right time in the right context."

Mayo Clinic noted that Anumana completed $25.7 million in Series A financing to fund further development and commercialisation of AI-enabled ECG and multimodal algorithms for clinical care, while Lucem completed $6 million in Series A financing to build out its platform for serving AI-generated diagnostic insights to the point-of-care.

To ensure you don't miss other Top Stories like these and news on key healthtech industry developments, sign up for our free daily e-newsletter here.  

Did you like this article?